Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on sale of Elektrosignal
Mandate

Vinge advises on sale of Elektrosignal

April 20, 2021 M&A Employment and Benefits

Vinge has advised the shareholders of Elektrosignal Invest Sthlm AB, which conducts operations within critical infrastructure, in conjunction with the sale thereof to NVBS, a Segulah portfolio company. The transaction includes the subsidiaries Elektrosignal Infra Sthlm AB, Infra Produkter Sthlm AB and Infra El Sthlm AB.

Vinge’s team primarily consisted of Johan Winnerblad and Åsa Gotthardsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026